Algert Global LLC Zynerba Pharmaceuticals, Inc. Transaction History

Algert Global LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.83 - $3.02 $36,367 - $60,016	-19,873 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $43,813 - $65,415	-15,213 Reduced 43.36%	19,873 $57,000
Q3 2021 Nov 15, 2021	BUY	$3.72 - $5.35 $34,848 - $50,118	9,368 Added 36.43%	35,086 $149,000
Q2 2021 Aug 13, 2021	BUY	$3.83 - $5.98 $18,920 - $29,541	4,940 Added 23.78%	25,718 $136,000
Q4 2020 Feb 12, 2021	SELL	$3.27 - $4.64 $98,917 - $140,360	-30,250 Reduced 59.28%	20,778 $69,000
Q3 2020 Nov 16, 2020	BUY	$3.23 - $4.3 $31,912 - $42,484	9,880 Added 24.01%	51,028 $169,000
Q2 2020 Aug 12, 2020	BUY	$3.31 - $6.54 $30,260 - $59,788	9,142 Added 28.56%	41,148 $139,000
Q1 2020 May 13, 2020	BUY	$2.9 - $6.16 $92,817 - $197,156	32,006 New	32,006 $123,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.